Abstract | INTRODUCTION: METHODS: RESULTS: A total of 413 patients entered this clinical trial from 25 centres in Japan. Significantly more patients in the aprepitant group achieved no vomiting overall and delayed phase than those in the control group (95.7% versus 83.6%, and 95.7% versus 84.7%, respectively). The aprepitant group also had statistically significantly higher percentages of no significant nausea, complete response and complete protection than the control group overall. In the control group, the percentages of no vomiting were higher in the second cycle than in the first cycle. The incidence of vomiting occurred day 7 or later was significantly higher in the control group compared with the aprepitant group. Other adverse events were not significant between the groups. CONCLUSION:
|
Authors | Junichi Nishimura, Taroh Satoh, Mutsumi Fukunaga, Hiroyoshi Takemoto, Ken Nakata, Yoshihito Ide, Takayuki Fukuzaki, Toshihiro Kudo, Yasuhiro Miyake, Masayoshi Yasui, Shunji Morita, Daisuke Sakai, Mamoru Uemura, Taishi Hata, Ichiro Takemasa, Tsunekazu Mizushima, Yuko Ohno, Hirofumi Yamamoto, Mitsugu Sekimoto, Riichiro Nezu, Yuichiro Doki, Masaki Mori, Multi-center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO) |
Journal | European journal of cancer (Oxford, England : 1990)
(Eur J Cancer)
Vol. 51
Issue 10
Pg. 1274-82
(Jul 2015)
ISSN: 1879-0852 [Electronic] England |
PMID | 25922233
(Publication Type: Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2015 Elsevier Ltd. All rights reserved. |
Chemical References |
- Antiemetics
- Morpholines
- Organoplatinum Compounds
- Oxaloacetates
- Oxaliplatin
- Deoxycytidine
- Aprepitant
- Capecitabine
- fosaprepitant
- Leucovorin
- Fluorouracil
|
Topics |
- Antiemetics
(adverse effects, therapeutic use)
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage, adverse effects, therapeutic use)
- Aprepitant
- Capecitabine
- Colorectal Neoplasms
(drug therapy)
- Deoxycytidine
(administration & dosage, adverse effects, analogs & derivatives)
- Drug Therapy, Combination
- Female
- Fluorouracil
(administration & dosage, adverse effects, analogs & derivatives)
- Humans
- Leucovorin
(administration & dosage, adverse effects)
- Male
- Middle Aged
- Morpholines
(adverse effects, therapeutic use)
- Nausea
(chemically induced, prevention & control)
- Organoplatinum Compounds
(administration & dosage, adverse effects)
- Oxaliplatin
- Oxaloacetates
- Vomiting
(prevention & control)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|